Loading...

Kristin Cadenhead

Title(s)Professor, Psychiatry
SchoolVc-health Sciences-schools
Address9500 Gilman Drive #
La Jolla CA 92093
vCardDownload vCard

    Collapse Overview 
    Collapse Overview

    Biography

    Dr. Kristin Cadenhead a Professor of Psychiatry at University of California San Diego and an attending physician at both the Veterans Administration and the UCSD Medical Centers. She serves as an Associate Residency Training Director for the Department of Psychiatry and a Clinical Foundations Director for the School of Medicine. She is the Director of the Cognitive Assessment and Risk Evaluation (CARE) Program, a research and clinical program that focuses on early identification, intervention and prevention of serious mental illness. Dr. Cadenhead is the Medical Director of the Mental Health Primary Care clinic at the VA Medical Center. She received her BA degree in Biology/Psychology from Rice University in Houston, Texas. She then earned her medical degree from the University of Texas Medical Branch in Galveston. She completed her residency in Psychiatry and Fellowship in Schizophrenia research at UCSD.

    Research Interests

    Primary research interests include vulnerability markers in the schizophrenia spectrum of disorders (prodromal schizophrenia and schizotypal personality disorder) and the genetics of schizophrenia. Dr. Cadenhead is the Director of the “CARE” (Cognitive Assessment and Risk Evaluation) Program to study the early signs of psychosis in adolescents and young adults. Funded by the National Institutes of Health, the CARE program provides education and community outreach to the National Alliance for the Mentally Ill, the San Diego Public Schools and other community health and physician organizations. The study is longitudinal and assesses clinical as well as physiologic and cognitive factors that may be predictive of developing schizophrenia. A major aim of the CARE program is to identify psychosis early so that it is possible to intervene earlier and perhaps prevent some of the devastating effects of schizophrenia. Dr. Cadenhead is also interested in the heritability of the information processing traits and participates in ongoing studies in normal twins. Dr. Cadenhead has expertise in the treatment of psychotic disorders and provides regular consultations.

    Clinical Focus

    The CARE Program provides clinical care to individuals who are developing the initial signs of a psychotic illness. The treatment philosophy includes a multidisciplinary approach with pharmacologic management, social services, stress management and psychoeducation as part of the program. Dr. Cadenhead is also the Director of the Psychiatry Primary Care Clinic at the SDVAMC. The Primary Care Clinic is staffed by psychiatry residents who provide both psychiatric and primary care to psychiatric patients while they are supervised by Attending Physicians in Psychiatry and Internal Medicine.

    Collapse Research 
    Collapse Research Activities and Funding
    3/3-Cognitive Behavioral Social Skills Training for Youth at Risk of Psychosis
    NIH/NIMH R01MH105243Sep 26, 2014 - Jul 31, 2019
    Role: Principal Investigator
    Compensatory Cognitive Training in Clinical High Risk Latino Youth
    NIH/NIMH R34MH105247Sep 12, 2014 - Jun 30, 2018
    Role: Principal Investigator
    Inflammatory Biomarkers in First Episode Psychosis: A Mexico/US Collaboration
    NIH/NIMH R21MH102374May 1, 2014 - Apr 30, 2016
    Role: Principal Investigator
    6/9-Predictors and Mechanisms of Conversion to Psychosis
    NIH/NIMH U01MH081944Dec 1, 2007 - Sep 24, 2014
    Role: Principal Investigator
    Vulnerability Markers in the Prodrome and First Episode of Schizophrenia
    NIH/NIMH K24MH076191Sep 29, 2007 - Jun 30, 2013
    Role: Principal Investigator
    Vulnerability Markers in Prodromal Schizophrenia
    NIH/NIMH R01MH060720Dec 1, 1999 - Jun 30, 2005
    Role: Principal Investigator
    INFORMATION PROCESSING DEFICITS IN SCHIZOTYPAL PATIENTS
    NIH/NIMH K20MH001124Apr 1, 1995 - Mar 31, 2001
    Role: Principal Investigator
    THE SCHIZOPHRENIC SPECTRUM AND INFORMATION PROCESSING
    NIH/NIMH F32MH010072Jan 1, 1993
    Role: Principal Investigator

    Collapse ORNG Applications 
    Collapse Clinical Trials
    Collapse Websites

    Collapse Bibliographic 
    Collapse Publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact us for help. to make corrections and additions.
    Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
    Altmetrics Details PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. Incorporating cortisol into the NAPLS2 individualized risk calculator for prediction of psychosis. Schizophr Res. 2020 Oct 09. Worthington MA, Walker EF, Addington J, Bearden CE, Cadenhead KS, Cornblatt BA, Mathalon DH, McGlashan TH, Perkins DO, Seidman LJ, Tsuang MT, Woods SW, Cannon TD. PMID: 33046334.
      View in: PubMed   Mentions:    Fields:    
    2. Concordance and factor structure of subthreshold positive symptoms in youth at clinical high risk for psychosis. Schizophr Res. 2020 Sep 14. Calkins ME, Woods SW, Bearden CE, Liu L, Moore TM, Cadenhead KS, Cannon TD, Cornblatt BA, McGlashan TH, Perkins DO, Seidman LJ, Tsuang MT, Walker EF, Mathalon DH, Keshavan M, Stone WS, Addington J. PMID: 32943313.
      View in: PubMed   Mentions:    Fields:    
    3. Evidence of Slow Neural Processing, Developmental Differences and Sensitivity to Cannabis Effects in a Sample at Clinical High Risk for Psychosis From the NAPLS Consortium Assessed With the Human Startle Paradigm. Front Psychiatry. 2020; 11:833. Cadenhead KS, Duncan E, Addington J, Bearden C, Cannon TD, Cornblatt BA, Mathalon D, McGlashan TH, Perkins DO, Seidman LJ, Tsuang M, Walker EF, Woods SW, Bauchman P, Belger A, Carrión RE, Donkers F, Johannesen J, Light G, Niznikiewicz M, Nunag J, Roach B. PMID: 33005152.
      View in: PubMed   Mentions:
    4. Associations between childhood adversity, cognitive schemas and attenuated psychotic symptoms. Early Interv Psychiatry. 2020 Aug 07. LoPilato AM, Zhang Y, Pike M, Addington J, Bearden CE, Cadenhead KS, Cannon TD, Cornblatt BA, Mathalon DH, McGlashan TH, Seidman L, Perkins DO, Tsuang MT, Woods SW, Walker EF. PMID: 32770658.
      View in: PubMed   Mentions:    Fields:    
    5. Deficits in auditory predictive coding in individuals with the psychosis risk syndrome: Prediction of conversion to psychosis. J Abnorm Psychol. 2020 Aug; 129(6):599-611. Fryer SL, Roach BJ, Hamilton HK, Bachman P, Belger A, Carrión RE, Duncan E, Johannesen J, Light GA, Niznikiewicz M, Addington J, Bearden CE, Cadenhead KS, Cannon TD, Cornblatt BA, McGlashan TH, Perkins DO, Seidman L, Tsuang M, Walker EF, Woods SW, Mathalon DH. PMID: 32757603.
      View in: PubMed   Mentions:    Fields:    
    6. Counterpoint. Early intervention for psychosis risk syndromes: Minimizing risk and maximizing benefit. Schizophr Res. 2020 May 10. Woods SW, Bearden CE, Sabb FW, Stone WS, Torous J, Cornblatt BA, Perkins DO, Cadenhead KS, Addington J, Powers AR, Mathalon DH, Calkins ME, Wolf DH, Corcoran CM, Horton LE, Mittal VA, Schiffman J, Ellman LM, Strauss GP, Mamah D, Choi J, Pearlson GD, Shah JL, Fusar-Poli P, Arango C, Perez J, Koutsouleris N, Wang J, Kwon JS, Walsh BC, McGlashan TH, Hyman SE, Gur RE, Cannon TD, Kane JM, Anticevic A. PMID: 32402605.
      View in: PubMed   Mentions: 1     Fields:    
    7. Cross-paradigm connectivity: reliability, stability, and utility. Brain Imaging Behav. 2020 May 02. Cao H, Chen OY, McEwen SC, Forsyth JK, Gee DG, Bearden CE, Addington J, Goodyear B, Cadenhead KS, Mirzakhanian H, Cornblatt BA, Carrión RE, Mathalon DH, McGlashan TH, Perkins DO, Belger A, Thermenos H, Tsuang MT, van Erp TGM, Walker EF, Hamann S, Anticevic A, Woods SW, Cannon TD. PMID: 32361945.
      View in: PubMed   Mentions:    Fields:    
    8. Persistent negative symptoms in youth at clinical high risk for psychosis: A longitudinal study. Schizophr Res. 2020 Apr 30. Devoe DJ, Lu L, Cannon TD, Cadenhead KS, Cornblatt BA, McGlashan TH, Perkins DO, Seidman LJ, Tsuang MT, Woods SW, Walker EF, Mathalon DH, Bearden CE, Addington J. PMID: 32362460.
      View in: PubMed   Mentions: 1     Fields:    
    9. North American Prodrome Longitudinal Study (NAPLS 3): Methods and baseline description. Schizophr Res. 2020 Apr 18. Addington J, Liu L, Brummitt K, Bearden CE, Cadenhead KS, Cornblatt BA, Keshavan M, Mathalon DH, McGlashan TH, Perkins DO, Seidman LJ, Stone W, Tsuang MT, Walker EF, Woods SW, Cannon TD. PMID: 32317224.
      View in: PubMed   Mentions:    Fields:    
    10. Stability of mismatch negativity event-related potentials in a multisite study. Int J Methods Psychiatr Res. 2020 06; 29(2):e1819. Roach BJ, Hamilton HK, Bachman P, Belger A, Carrión RE, Duncan E, Johannesen J, Kenney JG, Light G, Niznikiewicz M, Addington J, Bearden CE, Owens EM, Cadenhead KS, Cannon TD, Cornblatt BA, McGlashan TH, Perkins DO, Seidman L, Tsuang M, Walker EF, Woods SW, Mathalon DH. PMID: 32232944.
      View in: PubMed   Mentions: 1     Fields:    
    11. Stressor-Cortisol Concordance Among Individuals at Clinical High-Risk for Psychosis: Novel Findings from the NAPLS Cohort. Psychoneuroendocrinology. 2020 05; 115:104649. Cullen AE, Addington J, Bearden CE, Stone WS, Seidman LJ, Cadenhead KS, Cannon TD, Cornblatt BA, Mathalon DH, McGlashan TH, Perkins DO, Tsuang MT, Woods SW, Walker EF. PMID: 32197198.
      View in: PubMed   Mentions: 1     Fields:    
    12. Immuno-inflammatory changes across phases of early psychosis: The impact of antipsychotic medication and stage of illness. Schizophr Res. 2020 Feb 20. Kelsven S, de la Fuente-Sandoval C, Achim CL, Reyes-Madrigal F, Mirzakhanian H, Domingues I, Cadenhead K. PMID: 32089474.
      View in: PubMed   Mentions:    Fields:    
    13. Stress perception following childhood adversity: Unique associations with adversity type and sex. Dev Psychopathol. 2020 02; 32(1):343-356. LoPilato AM, Addington J, Bearden CE, Cadenhead KS, Cannon TD, Cornblatt BA, Mathalon DH, McGlashan TH, Perkins DO, Tsuang MT, Woods SW, Walker EF. PMID: 30846020.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    14. Childhood trauma and cognitive functioning in individuals at clinical high risk (CHR) for psychosis. Dev Psychopathol. 2020 Jan 21; 1-12. Velikonja T, Velthorst E, Zinberg J, Cannon TD, Cornblatt BA, Perkins DO, Cadenhead KS, Tsuang MT, Addington J, Woods SW, McGlashan T, Mathalon DH, Stone W, Keshavan M, Seidman L, Bearden CE. PMID: 31959269.
      View in: PubMed   Mentions: 1     Fields:    
    15. Selection for psychosocial treatment for youth at clinical high risk for psychosis based on the North American Prodrome Longitudinal Study individualized risk calculator. Early Interv Psychiatry. 2020 Jan 14. Worthington MA, Miklowitz DJ, O'Brien M, Addington J, Bearden CE, Cadenhead KS, Cornblatt BA, Mathalon DH, McGlashan TH, Perkins DO, Seidman LJ, Tsuang MT, Walker EF, Woods SW, Cannon TD. PMID: 31943807.
      View in: PubMed   Mentions:    Fields:    
    16. Compensatory Cognitive Training for Latino Youth at Clinical High Risk for Psychosis: Study Protocol for a Randomized Controlled Trial. Front Psychiatry. 2019; 10:951. Mahmood Z, Kelsven S, Cadenhead K, Wyckoff J, Reyes-Madrigal F, de la Fuente-Sandoval C, Twamley EW. PMID: 31998163.
      View in: PubMed   Mentions:
    17. Predictive validity of conversion from the clinical high risk syndrome to frank psychosis. Schizophr Res. 2020 02; 216:184-191. Yoviene Sykes LA, Ferrara M, Addington J, Bearden CE, Cadenhead KS, Cannon TD, Cornblatt BA, Perkins DO, Mathalon DH, Seidman LJ, Tsuang MT, Walker EF, McGlashan TH, Woodberry KA, Powers AR, Ponce AN, Cahill JD, Pollard JM, Srihari VH, Woods SW. PMID: 31864837.
      View in: PubMed   Mentions:    Fields:    
    18. Duration of the psychosis prodrome. Schizophr Res. 2020 02; 216:443-449. Powers AR, Addington J, Perkins DO, Bearden CE, Cadenhead KS, Cannon TD, Cornblatt BA, Mathalon DH, Seidman LJ, Tsuang MT, Walker EF, McGlashan TH, Woods SW. PMID: 31806523.
      View in: PubMed   Mentions: 2     Fields:    
    19. Polygenic Risk Score Contribution to Psychosis Prediction in a Target Population of Persons at Clinical High Risk. Am J Psychiatry. 2020 02 01; 177(2):155-163. Perkins DO, Olde Loohuis L, Barbee J, Ford J, Jeffries CD, Addington J, Bearden CE, Cadenhead KS, Cannon TD, Cornblatt BA, Mathalon DH, McGlashan TH, Seidman LJ, Tsuang M, Walker EF, Woods SW. PMID: 31711302.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    20. Characterizing Covariant Trajectories of Individuals at Clinical High Risk for Psychosis Across Symptomatic and Functional Domains. Am J Psychiatry. 2020 02 01; 177(2):164-171. Allswede DM, Addington J, Bearden CE, Cadenhead KS, Cornblatt BA, Mathalon DH, McGlashan T, Perkins DO, Seidman LJ, Tsuang MT, Walker EF, Woods SW, Cannon TD. PMID: 31509005.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    21. Association Between P300 Responses to Auditory Oddball Stimuli and Clinical Outcomes in the Psychosis Risk Syndrome. JAMA Psychiatry. 2019 Aug 07. Hamilton HK, Roach BJ, Bachman PM, Belger A, Carrion RE, Duncan E, Johannesen JK, Light GA, Niznikiewicz MA, Addington J, Bearden CE, Cadenhead KS, Cornblatt BA, McGlashan TH, Perkins DO, Seidman LJ, Tsuang MT, Walker EF, Woods SW, Cannon TD, Mathalon DH. PMID: 31389974.
      View in: PubMed   Mentions: 5     Fields:    
    22. Sleep problems and attenuated psychotic symptoms in youth at clinical high-risk for psychosis. Psychiatry Res. 2019 12; 282:112492. Goines KB, LoPilato AM, Addington J, Bearden CE, Cadenhead KS, Cannon TD, Cornblatt BA, Mathalon DH, McGlashan TH, Perkins DO, Tsuang MT, Woods SW, Walker EF. PMID: 31387769.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    23. The Global Functioning: Social and Role Scales-Further Validation in a Large Sample of Adolescents and Young Adults at Clinical High Risk for Psychosis. Schizophr Bull. 2019 06 18; 45(4):763-772. Carrión RE, Auther AM, McLaughlin D, Olsen R, Addington J, Bearden CE, Cadenhead KS, Cannon TD, Mathalon DH, McGlashan TH, Perkins DO, Seidman LJ, Tsuang MT, Walker EF, Woods SW, Cornblatt BA. PMID: 30351423.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    24. Altered Brain Activation During Memory Retrieval Precedes and Predicts Conversion to Psychosis in Individuals at Clinical High Risk. Schizophr Bull. 2019 06 18; 45(4):924-933. Cao H, McEwen SC, Chung Y, Chén OY, Bearden CE, Addington J, Goodyear B, Cadenhead KS, Mirzakhanian H, Cornblatt BA, Carrión RE, Mathalon DH, McGlashan TH, Perkins DO, Belger A, Seidman LJ, Thermenos H, Tsuang MT, van Erp TGM, Walker EF, Hamann S, Anticevic A, Woods SW, Cannon TD. PMID: 30215784.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    25. Cortical abnormalities in youth at clinical high-risk for psychosis: Findings from the NAPLS2 cohort. Neuroimage Clin. 2019; 23:101862. Chung Y, Allswede D, Addington J, Bearden CE, Cadenhead K, Cornblatt B, Mathalon DH, McGlashan T, Perkins D, Seidman LJ, Tsuang M, Walker E, Woods SW, McEwen S, van Erp TGM, Cannon TD. PMID: 31150956.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    26. Toward Leveraging Human Connectomic Data in Large Consortia: Generalizability of fMRI-Based Brain Graphs Across Sites, Sessions, and Paradigms. Cereb Cortex. 2019 03 01; 29(3):1263-1279. Cao H, McEwen SC, Forsyth JK, Gee DG, Bearden CE, Addington J, Goodyear B, Cadenhead KS, Mirzakhanian H, Cornblatt BA, Carrión RE, Mathalon DH, McGlashan TH, Perkins DO, Belger A, Seidman LJ, Thermenos H, Tsuang MT, van Erp TGM, Walker EF, Hamann S, Anticevic A, Woods SW, Cannon TD. PMID: 29522112.
      View in: PubMed   Mentions: 5     Fields:    Translation:Humans
    27. Clinical Profiles and Conversion Rates Among Young Individuals With Autism Spectrum Disorder Who Present to Clinical High Risk for Psychosis Services. J Am Acad Child Adolesc Psychiatry. 2019 06; 58(6):582-588. Foss-Feig JH, Velthorst E, Smith L, Reichenberg A, Addington J, Cadenhead KS, Cornblatt BA, Mathalon DH, McGlashan TH, Perkins DO, Seidman LJ, Stone WS, Keshavan M, Tsuang MT, Walker EF, Woods SW, Cannon TD, Bearden CE. PMID: 30797038.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    28. The Early Psychosis Screener for Internet (EPSI)-SR: Predicting 12 month psychotic conversion using machine learning. Schizophr Res. 2019 06; 208:390-396. Brodey BB, Girgis RR, Favorov OV, Bearden CE, Woods SW, Addington J, Perkins DO, Walker EF, Cornblatt BA, Brucato G, Purcell SE, Brodey IS, Cadenhead KS. PMID: 30777603.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    29. Impact of childhood adversity on corticolimbic volumes in youth at clinical high-risk for psychosis. Schizophr Res. 2019 11; 213:48-55. LoPilato AM, Goines K, Addington J, Bearden CE, Cadenhead KS, Cannon TD, Cornblatt BA, Mathalon DH, McGlashan TH, Seidman L, Perkins DO, Tsuang MT, Woods SW, Walker EF. PMID: 30745068.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    30. Adding a neuroanatomical biomarker to an individualized risk calculator for psychosis: A proof-of-concept study. Schizophr Res. 2019 06; 208:41-43. Chung Y, Addington J, Bearden CE, Cadenhead K, Cornblatt B, Mathalon DH, McGlashan T, Perkins D, Seidman LJ, Tsuang M, Walker E, Woods SW, McEwen S, van Erp TGM, Cannon TD. PMID: 30745066.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    31. Progressive reconfiguration of resting-state brain networks as psychosis develops: Preliminary results from the North American Prodrome Longitudinal Study (NAPLS) consortium. Schizophr Res. 2019 Jan 28. Cao H, Chung Y, McEwen SC, Bearden CE, Addington J, Goodyear B, Cadenhead KS, Mirzakhanian H, Cornblatt BA, Carrión R, Mathalon DH, McGlashan TH, Perkins DO, Belger A, Seidman LJ, Thermenos H, Tsuang MT, van Erp TGM, Walker EF, Hamann S, Anticevic A, Woods SW, Cannon TD. PMID: 30704864.
      View in: PubMed   Mentions: 4     Fields:    
    32. Association of baseline inflammatory markers and the development of negative symptoms in individuals at clinical high risk for psychosis. Brain Behav Immun. 2019 02; 76:268-274. Goldsmith DR, Haroon E, Miller AH, Addington J, Bearden C, Cadenhead K, Cannon T, Cornblatt B, Mathalon D, McGlashan T, Seidman L, Tsuang M, Woods SW, Walker EF, Perkins DO. PMID: 30496778.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    33. Tobacco use and psychosis risk in persons at clinical high risk. Early Interv Psychiatry. 2019 10; 13(5):1173-1181. Ward HB, Lawson MT, Addington J, Bearden CE, Cadenhead KS, Cannon TD, Cornblatt BA, Jeffries CD, Mathalon DH, McGlashan TH, Seidman LJ, Tsuang MT, Walker EF, Woods SW, Perkins DO. PMID: 30362261.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    34. Metabolic abnormalities and low dietary Omega 3 are associated with symptom severity and worse functioning prior to the onset of psychosis: Findings from the North American Prodrome Longitudinal Studies Consortium. Schizophr Res. 2019 02; 204:96-103. Cadenhead KS, Minichino A, Kelsven S, Addington J, Bearden C, Cannon TD, Cornblatt BA, Mathalon D, McGlashan TH, Perkins DO, Seidman LJ, Tsuang M, Walker EF, Woods SW, Yao J. PMID: 30249470.
      View in: PubMed   Mentions: 8     Fields:    Translation:Humans
    35. Cerebello-thalamo-cortical hyperconnectivity as a state-independent functional neural signature for psychosis prediction and characterization. Nat Commun. 2018 09 21; 9(1):3836. Cao H, Chén OY, Chung Y, Forsyth JK, McEwen SC, Gee DG, Bearden CE, Addington J, Goodyear B, Cadenhead KS, Mirzakhanian H, Cornblatt BA, Carrión RE, Mathalon DH, McGlashan TH, Perkins DO, Belger A, Seidman LJ, Thermenos H, Tsuang MT, van Erp TGM, Walker EF, Hamann S, Anticevic A, Woods SW, Cannon TD. PMID: 30242220.
      View in: PubMed   Mentions: 16     Fields:    Translation:Humans
    36. Clinical and functional characteristics of youth at clinical high-risk for psychosis who do not transition to psychosis. Psychol Med. 2019 07; 49(10):1670-1677. Addington J, Stowkowy J, Liu L, Cadenhead KS, Cannon TD, Cornblatt BA, McGlashan TH, Perkins DO, Seidman LJ, Tsuang MT, Walker EF, Bearden CE, Mathalon DH, Santesteban-Echarri O, Woods SW. PMID: 30176955.
      View in: PubMed   Mentions: 9     Fields:    Translation:Humans
    37. Longitudinal changes in social cognition in individuals at clinical high risk for psychosis: An outcome based analysis. Schizophr Res. 2019 02; 204:334-336. Shakeel MK, Lu L, Cannon TD, Cadenhead KS, Cornblatt BA, McGlashan TH, Perkins DO, Seidman LJ, Tsuang MT, Woods SW, Walker EF, Mathalon DH, Bearden CE, Addington J. PMID: 30181061.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    38. Use of Machine Learning to Determine Deviance in Neuroanatomical Maturity Associated With Future Psychosis in Youths at Clinically High Risk. JAMA Psychiatry. 2018 09 01; 75(9):960-968. Chung Y, Addington J, Bearden CE, Cadenhead K, Cornblatt B, Mathalon DH, McGlashan T, Perkins D, Seidman LJ, Tsuang M, Walker E, Woods SW, McEwen S, van Erp TGM, Cannon TD. PMID: 29971330.
      View in: PubMed   Mentions: 11     Fields:    Translation:Humans
    39. Neurocognitive profiles in the prodrome to psychosis in NAPLS-1. Schizophr Res. 2019 02; 204:311-319. Velthorst E, Meyer EC, Giuliano AJ, Addington J, Cadenhead KS, Cannon TD, Cornblatt BA, McGlashan TH, Perkins DO, Tsuang MT, Walker EF, Woods SW, Bearden CE, Seidman LJ. PMID: 30078717.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    40. The relation of atypical antipsychotic use and stress with weight in individuals at clinical high risk for psychosis. Stress Health. 2018 Dec; 34(5):591-600. Hampton JN, Trotman HD, Addington J, Bearden CE, Cadenhead KS, Cannon TD, Cornblatt BA, Mathalon DH, McGlashan TH, Tsuang MT, Perkins DO, Seidman LJ, Woods SW, Walker EF. PMID: 29956456.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    41. Networks of blood proteins in the neuroimmunology of schizophrenia. Transl Psychiatry. 2018 06 06; 8(1):112. Jeffries CD, Perkins DO, Fournier M, Do KQ, Cuenod M, Khadimallah I, Domenici E, Addington J, Bearden CE, Cadenhead KS, Cannon TD, Cornblatt BA, Mathalon DH, McGlashan TH, Seidman LJ, Tsuang M, Walker EF, Woods SW. PMID: 29875399.
      View in: PubMed   Mentions: 6     Fields:    Translation:Humans
    42. Lack of Diagnostic Pluripotentiality in Patients at Clinical High Risk for Psychosis: Specificity of Comorbidity Persistence and Search for Pluripotential Subgroups. Schizophr Bull. 2018 02 15; 44(2):254-263. Woods SW, Powers AR, Taylor JH, Davidson CA, Johannesen JK, Addington J, Perkins DO, Bearden CE, Cadenhead KS, Cannon TD, Cornblatt BA, Seidman LJ, Tsuang MT, Walker EF, McGlashan TH. PMID: 29036402.
      View in: PubMed   Mentions: 12     Fields:    Translation:Humans
    43. Latent class cluster analysis of symptom ratings identifies distinct subgroups within the clinical high risk for psychosis syndrome. Schizophr Res. 2018 07; 197:522-530. Ryan AT, Addington J, Bearden CE, Cadenhead KS, Cornblatt BA, Mathalon DH, McGlashan TH, Perkins DO, Seidman LJ, Tsuang MT, Woods SW, Cannon TD, Walker EF. PMID: 29279247.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    44. Exploration of clinical high-risk dropouts. Schizophr Res. 2018 05; 195:579-580. Stowkowy J, Liu L, Cadenhead KS, Tsuang MT, Cannon TD, Cornblatt BA, McGlashan TH, Woods SW, Perkins DO, Seidman LJ, Walker EF, Bearden CE, Mathalon DH, Addington J. PMID: 28964651.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    45. Perceptual abnormalities in clinical high risk youth and the role of trauma, cannabis use and anxiety. Psychiatry Res. 2017 12; 258:462-468. Lu Y, Marshall C, Cadenhead KS, Cannon TD, Cornblatt BA, McGlashan TH, Perkins DO, Seidman LJ, Tsuang MT, Walker EF, Woods SW, Bearden CE, Mathalon D, Addington J. PMID: 28886901.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    46. The role of a family history of psychosis for youth at clinical high risk of psychosis. Early Interv Psychiatry. 2019 Apr; 13(2):251-256. Georgopoulos G, Stowkowy J, Liu L, Cadenhead KS, Cannon TD, Cornblatt BA, McGlashan TH, Perkins DO, Seidman LJ, Tsuang MT, Walker EF, Woods SW, Bearden CE, Mathalon DH, Addington J. PMID: 28792113.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    47. Changes in symptom content from a clinical high-risk state to conversion to psychosis. Early Interv Psychiatry. 2019 Apr; 13(2):257-263. Marshall C, Lu Y, Lyngberg K, Deighton S, Cadenhead KS, Cannon TD, Cornblatt BA, McGlashan TH, Perkins DO, Seidman LJ, Tsuang MT, Walker EF, Woods SW, Bearden CE, Mathalon D, Addington J. PMID: 28771938.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    48. Depression and clinical high-risk states: Baseline presentation of depressed vs. non-depressed participants in the NAPLS-2 cohort. Schizophr Res. 2018 02; 192:357-363. Kline ER, Seidman LJ, Cornblatt BA, Woodberry KA, Bryant C, Bearden CE, Cadenhead KS, Cannon TD, Mathalon DH, McGlashan TH, Perkins DO, Tsuang MT, Walker EF, Woods SW, Addington J. PMID: 28578922.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    49. Potentially important periods of change in the development of social and role functioning in youth at clinical high risk for psychosis. Dev Psychopathol. 2018 02; 30(1):39-47. Velthorst E, Zinberg J, Addington J, Cadenhead KS, Cannon TD, Carrión RE, Auther A, Cornblatt BA, McGlashan TH, Mathalon DH, Perkins DO, Seidman LJ, Tsuang MT, Walker EF, Woods SW, Reichenberg A, Bearden CE. PMID: 28420458.
      View in: PubMed   Mentions: 5     Fields:    Translation:Humans
    50. Comorbid diagnoses for youth at clinical high risk of psychosis. Schizophr Res. 2017 12; 190:90-95. Addington J, Piskulic D, Liu L, Lockwood J, Cadenhead KS, Cannon TD, Cornblatt BA, McGlashan TH, Perkins DO, Seidman LJ, Tsuang MT, Walker EF, Bearden CE, Mathalon DH, Woods SW. PMID: 28372906.
      View in: PubMed   Mentions: 13     Fields:    Translation:Humans
    51. Investigating the link between drug-naive first episode psychoses (FEPs), weight gain abnormalities and brain structural damages: Relevance and implications for therapy. Prog Neuropsychopharmacol Biol Psychiatry. 2017 07 03; 77:9-22. Minichino A, Ando' A, Francesconi M, Salatino A, Delle Chiaie R, Cadenhead K. PMID: 28363765.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    52. Ventricular enlargement and progressive reduction of cortical gray matter are linked in prodromal youth who develop psychosis. Schizophr Res. 2017 11; 189:169-174. Chung Y, Haut KM, He G, van Erp TGM, McEwen S, Addington J, Bearden CE, Cadenhead K, Cornblatt B, Mathalon DH, McGlashan T, Perkins D, Seidman LJ, Tsuang M, Walker E, Woods SW, Cannon TD. PMID: 28245961.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    53. The Role of microRNA Expression in Cortical Development During Conversion to Psychosis. Neuropsychopharmacology. 2017 Oct; 42(11):2188-2195. Zheutlin AB, Jeffries CD, Perkins DO, Chung Y, Chekroud AM, Addington J, Bearden CE, Cadenhead KS, Cornblatt BA, Mathalon DH, McGlashan TH, Seidman LJ, Walker EF, Woods SW, Tsuang M, Cannon TD. PMID: 28186095.
      View in: PubMed   Mentions: 4     Fields:    Translation:HumansCells
    54. From neurological soft signs to functional outcome in young individuals in treatment with secondary services for non-psychotic disorders: a path analysis. Psychol Med. 2017 May; 47(7):1192-1203. Minichino A, Francesconi M, Carrión RE, Delle Chiaie R, Bevilacqua A, Parisi M, Rullo S, Bersani FS, Biondi M, Cadenhead K. PMID: 28052777.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    55. Mirror Neurons in Psychiatric Disorders: from Neuroception to Bio-behavioral System Dysregulation. Neuropsychopharmacology. 2017 01; 42(1):366. Minichino A, Cadenhead K. PMID: 27909332.
      View in: PubMed   Mentions: 1     Fields:    Translation:HumansCells
    56. Prediction of functional outcome in young patients with a recent-onset psychiatric disorder: Beyond the traditional diagnostic classification system. Schizophr Res. 2017 07; 185:114-121. Minichino A, Francesconi M, Carrión RE, Bevilacqua A, Parisi M, Rullo S, Ando' A, Biondi M, Delle Chiaie R, Cadenhead K. PMID: 28041918.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    57. Psychosis prediction in secondary mental health services. A broad, comprehensive approach to the "at risk mental state" syndrome. Eur Psychiatry. 2017 02; 40:96-104. Francesconi M, Minichino A, Carrión RE, Delle Chiaie R, Bevilacqua A, Parisi M, Rullo S, Bersani FS, Biondi M, Cadenhead K. PMID: 27992839.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    58. Insights into psychosis risk from leukocyte microRNA expression. Transl Psychiatry. 2016 12 13; 6(12):e981. Jeffries CD, Perkins DO, Chandler SD, Stark T, Yeo E, Addington J, Bearden CE, Cadenhead KS, Cannon TD, Cornblatt BA, Mathalon DH, McGlashan TH, Seidman LJ, Walker EF, Woods SW, Glatt SJ, Tsuang M. PMID: 27959328.
      View in: PubMed   Mentions: 8     Fields:    Translation:HumansCells
    59. Association of Neurocognition With Transition to Psychosis: Baseline Functioning in the Second Phase of the North American Prodrome Longitudinal Study. JAMA Psychiatry. 2016 Dec 01; 73(12):1239-1248. Seidman LJ, Shapiro DI, Stone WS, Woodberry KA, Ronzio A, Cornblatt BA, Addington J, Bearden CE, Cadenhead KS, Cannon TD, Mathalon DH, McGlashan TH, Perkins DO, Tsuang MT, Walker EF, Woods SW. PMID: 27806157.
      View in: PubMed   Mentions: 41     Fields:    Translation:Humans
    60. Multisite reliability of MR-based functional connectivity. Neuroimage. 2017 02 01; 146:959-970. Noble S, Scheinost D, Finn ES, Shen X, Papademetris X, McEwen SC, Bearden CE, Addington J, Goodyear B, Cadenhead KS, Mirzakhanian H, Cornblatt BA, Olvet DM, Mathalon DH, McGlashan TH, Perkins DO, Belger A, Seidman LJ, Thermenos H, Tsuang MT, van Erp TGM, Walker EF, Hamann S, Woods SW, Cannon TD, Constable RT. PMID: 27746386.
      View in: PubMed   Mentions: 27     Fields:    Translation:Humans
    61. Theory of Mind as a mediator variable between neurocognition and functioning in young individuals in treatment with secondary services for non-psychotic disorders. Psychiatry Res. 2016 Dec 30; 246:415-420. Francesconi M, Minichino A, Carrión RE, Chiaie RD, Bevilacqua A, Parisi M, Rullo S, Bersani FS, Biondi M, Cadenhead K. PMID: 27788462.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    62. Treatment Precedes Positive Symptoms in North American Adolescent and Young Adult Clinical High Risk Cohort. J Clin Child Adolesc Psychol. 2018 Jan-Feb; 47(1):69-78. Woodberry KA, Seidman LJ, Bryant C, Addington J, Bearden CE, Cadenhead KS, Cannon TD, Cornblatt BA, McGlashan TH, Mathalon DH, Perkins DO, Tsuang MT, Walker EF, Woods SW. PMID: 27705009.
      View in: PubMed   Mentions: 6     Fields:    Translation:Humans
    63. An Individualized Risk Calculator for Research in Prodromal Psychosis. Am J Psychiatry. 2016 Oct 01; 173(10):980-988. Cannon TD, Yu C, Addington J, Bearden CE, Cadenhead KS, Cornblatt BA, Heinssen R, Jeffries CD, Mathalon DH, McGlashan TH, Perkins DO, Seidman LJ, Tsuang MT, Walker EF, Woods SW, Kattan MW. PMID: 27363508.
      View in: PubMed   Mentions: 81     Fields:    Translation:Humans
    64. Relation between cannabis use and subcortical volumes in people at clinical high risk of psychosis. Psychiatry Res Neuroimaging. 2016 Aug 30; 254:3-9. Buchy L, Mathalon DH, Cannon TD, Cadenhead KS, Cornblatt BA, McGlashan TH, Perkins DO, Seidman LJ, Tsuang MT, Walker EF, Woods SW, Bearden CE, Addington J. PMID: 27289213.
      View in: PubMed   Mentions: 1     Fields:    Translation:HumansAnimals
    65. Traumatic brain injury in individuals at clinical high risk for psychosis. Schizophr Res. 2016 07; 174(1-3):77-81. Deighton S, Buchy L, Cadenhead KS, Cannon TD, Cornblatt BA, McGlashan TH, Perkins DO, Seidman LJ, Tsuang MT, Walker EF, Woods SW, Bearden CE, Mathalon D, Addington J. PMID: 27165121.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    66. The Violent Content in Attenuated Psychotic Symptoms. Psychiatry Res. 2016 Aug 30; 242:61-66. Marshall C, Deighton S, Cadenhead KS, Cannon TD, Cornblatt BA, McGlashan TH, Perkins DO, Seidman LJ, Tsuang MT, Walker EF, Woods SW, Bearden CE, Mathalon D, Addington J. PMID: 27259137.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    67. Prioritizing schizophrenia endophenotypes for future genetic studies: An example using data from the COGS-1 family study. Schizophr Res. 2016 07; 174(1-3):1-9. Millard SP, Shofer J, Braff D, Calkins M, Cadenhead K, Freedman R, Green MF, Greenwood TA, Gur R, Gur R, Lazzeroni LC, Light GA, Olincy A, Nuechterlein K, Seidman L, Siever L, Silverman J, Stone WS, Sprock J, Sugar CA, Swerdlow NR, Tsuang M, Turetsky B, Radant A, Tsuang DW. PMID: 27132484.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    68. Functional Capacity Assessed by the Map Task in Individuals at Clinical High-Risk for Psychosis. Schizophr Bull. 2016 09; 42(5):1234-42. McLaughlin D, Carrión RE, Auther AM, Olvet DM, Addington J, Bearden CE, Cadenhead KS, Cannon TD, Heinssen RK, Mathalon DH, McGlashan TH, Perkins DO, Seidman LJ, Tsuang MT, Walker EF, Woods SW, Goldberg TE, Harvey PD, Cornblatt BA. PMID: 27105902.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    69. A Case of Attenuated Psychosis Syndrome: A Broad Differential Diagnosis Requires Broad-Spectrum Treatment. Am J Psychiatry. 2016 Apr 01; 173(4):321-9. Cadenhead KS, Mirzakhanian H. PMID: 27035531.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    70. Altering the course of schizophrenia: progress and perspectives. Nat Rev Drug Discov. 2016 07; 15(7):485-515. Millan MJ, Andrieux A, Bartzokis G, Cadenhead K, Dazzan P, Fusar-Poli P, Gallinat J, Giedd J, Grayson DR, Heinrichs M, Kahn R, Krebs MO, Leboyer M, Lewis D, Marin O, Marin P, Meyer-Lindenberg A, McGorry P, McGuire P, Owen MJ, Patterson P, Sawa A, Spedding M, Uhlhaas P, Vaccarino F, Wahlestedt C, Weinberger D. PMID: 26939910.
      View in: PubMed   Mentions: 79     Fields:    Translation:Humans
    71. The relations of age and pubertal development with cortisol and daily stress in youth at clinical risk for psychosis. Schizophr Res. 2016 Apr; 172(1-3):29-34. Moskow DM, Addington J, Bearden CE, Cadenhead KS, Cornblatt BA, Heinssen R, Mathalon DH, McGlashan TH, Perkins DO, Seidman LJ, Tsuang MT, Cannon TD, Woods SW, Walker EF. PMID: 26905038.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    72. Healthy adolescent performance on the MATRICS Consensus Cognitive Battery (MCCB): Developmental data from two samples of volunteers. Schizophr Res. 2016 Apr; 172(1-3):106-13. Stone WS, Mesholam-Gately RI, Giuliano AJ, Woodberry KA, Addington J, Bearden CE, Cadenhead KS, Cannon TD, Cornblatt BA, Mathalon DH, McGlashan TH, Perkins DO, Tsuang MT, Walker EF, Woods SW, McCarley RW, Heinssen R, Green MF, Nuechterlein K, Seidman LJ. PMID: 26896388.
      View in: PubMed   Mentions: 5     Fields:    Translation:Humans
    73. Early traumatic experiences, perceived discrimination and conversion to psychosis in those at clinical high risk for psychosis. Soc Psychiatry Psychiatr Epidemiol. 2016 Apr; 51(4):497-503. Stowkowy J, Liu L, Cadenhead KS, Cannon TD, Cornblatt BA, McGlashan TH, Perkins DO, Seidman LJ, Tsuang MT, Walker EF, Woods SW, Bearden CE, Mathalon DH, Addington J. PMID: 26851943.
      View in: PubMed   Mentions: 10     Fields:    Translation:Humans
    74. Biological Motion induced mu suppression is reduced in Early Psychosis (EP) patients with active negative symptoms and Autism Spectrum Disorders (ASD). Psychiatry Res. 2016 Apr 30; 238:374-377. Minichino A, Singh F, Pineda J, Friederich E, Cadenhead KS. PMID: 26970656.
      View in: PubMed   Mentions: 2     Fields:    Translation:HumansCells
    75. Social cognition over time in individuals at clinical high risk for psychosis: Findings from the NAPLS-2 cohort. Schizophr Res. 2016 Mar; 171(1-3):176-81. Piskulic D, Liu L, Cadenhead KS, Cannon TD, Cornblatt BA, McGlashan TH, Perkins DO, Seidman LJ, Tsuang MT, Walker EF, Woods SW, Bearden CE, Mathalon DH, Addington J. PMID: 26785807.
      View in: PubMed   Mentions: 9     Fields:    Translation:Humans
    76. Effects of intranasal oxytocin on neural processing within a socially relevant neural circuit. Eur Neuropsychopharmacol. 2016 Mar; 26(3):626-30. Singh F, Nunag J, Muldoon G, Cadenhead KS, Pineda JA, Feifel D. PMID: 26727038.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    77. Evaluating the relationship between cannabis use and IQ in youth and young adults at clinical high risk of psychosis. Psychiatry Res. 2015 Dec 30; 230(3):878-84. Buchy L, Seidman LJ, Cadenhead KS, Cannon TD, Cornblatt BA, McGlashan TH, Perkins DO, Stone W, Tsuang MT, Walker EF, Woods SW, Bearden CE, Mathalon DH, Addington J. PMID: 26626949.
      View in: PubMed   Mentions: 5     Fields:    Translation:Humans
    78. Evaluating the impact of cannabis use on thalamic connectivity in youth at clinical high risk of psychosis. BMC Psychiatry. 2015 Nov 09; 15:276. Buchy L, Cannon TD, Anticevic A, Lyngberg K, Cadenhead KS, Cornblatt BA, McGlashan TH, Perkins DO, Seidman LJ, Tsuang MT, Walker EF, Woods SW, Bearden CE, Mathalon DH, Addington J. PMID: 26553191.
      View in: PubMed   Mentions: 6     Fields:    Translation:Humans
    79. Anxiety in youth at clinical high risk for psychosis. Early Interv Psychiatry. 2017 12; 11(6):480-487. McAusland L, Buchy L, Cadenhead KS, Cannon TD, Cornblatt BA, Heinssen R, McGlashan TH, Perkins DO, Seidman LJ, Tsuang MT, Walker EF, Woods SW, Bearden CE, Mathalon DH, Addington J. PMID: 26456932.
      View in: PubMed   Mentions: 11     Fields:    Translation:Humans
    80. Severity of thought disorder predicts psychosis in persons at clinical high-risk. Schizophr Res. 2015 Dec; 169(1-3):169-177. Perkins DO, Jeffries CD, Cornblatt BA, Woods SW, Addington J, Bearden CE, Cadenhead KS, Cannon TD, Heinssen R, Mathalon DH, Seidman LJ, Tsuang MT, Walker EF, McGlashan TH. PMID: 26441004.
      View in: PubMed   Mentions: 10     Fields:    Translation:Humans
    81. Association of Thalamic Dysconnectivity and Conversion to Psychosis in Youth and Young Adults at Elevated Clinical Risk. JAMA Psychiatry. 2015 Sep; 72(9):882-91. Anticevic A, Haut K, Murray JD, Repovs G, Yang GJ, Diehl C, McEwen SC, Bearden CE, Addington J, Goodyear B, Cadenhead KS, Mirzakhanian H, Cornblatt BA, Olvet D, Mathalon DH, McGlashan TH, Perkins DO, Belger A, Seidman LJ, Tsuang MT, van Erp TG, Walker EF, Hamann S, Woods SW, Qiu M, Cannon TD. PMID: 26267151.
      View in: PubMed   Mentions: 83     Fields:    Translation:Humans
    82. Specificity of Incident Diagnostic Outcomes in Patients at Clinical High Risk for Psychosis. Schizophr Bull. 2015 Sep; 41(5):1066-75. Webb JR, Addington J, Perkins DO, Bearden CE, Cadenhead KS, Cannon TD, Cornblatt BA, Heinssen RK, Seidman LJ, Tarbox SI, Tsuang MT, Walker EF, McGlashan TH, Woods SW. PMID: 26272875.
      View in: PubMed   Mentions: 20     Fields:    Translation:Humans
    83. Demographic correlates of attenuated positive psychotic symptoms. Schizophr Res. 2015 Aug; 166(1-3):31-6. Waford RN, MacDonald A, Goines K, Novacek DM, Trotman HD, Elaine F W, Addington J, Bearden CE, Cadenhead KS, Cannon TD, Cornblatt BA, Heinssen R, Mathalon DH, Tsuang MT, Perkins DO, Seidman LJ, Woods SW, McGlashan TH. PMID: 25999040.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    84. Theory of Mind, Emotion Recognition and Social Perception in Individuals at Clinical High Risk for Psychosis: findings from the NAPLS-2 cohort. Schizophr Res Cogn. 2015 Sep; 2(3):133-139. Barbato M, Liu L, Cadenhead KS, Cannon TD, Cornblatt BA, McGlashan TH, Perkins DO, Seidman LJ, Tsuang MT, Walker EF, Woods SW, Bearden CE, Mathalon DH, Heinssen R, Addington J. PMID: 27695675.
      View in: PubMed   Mentions:
    85. Prodromal Symptom Severity Predicts Accelerated Gray Matter Reduction and Third Ventricle Expansion Among Clinically High Risk Youth Developing Psychotic Disorders. Mol Neuropsychiatry. 2015 May 01; 1(1):13-22. Chung Y, Jacobson A, He G, van Erp TG, McEwen S, Addington J, Bearden CE, Cadenhead K, Cornblatt B, Mathalon DH, McGlashan T, Perkins D, Seidman LJ, Tsuang M, Walker E, Woods SW, Heinssen R, Cannon TD. PMID: 26005673.
      View in: PubMed   Mentions:
    86. North American Prodrome Longitudinal Study (NAPLS 2): The Prodromal Symptoms. J Nerv Ment Dis. 2015 May; 203(5):328-35. Addington J, Liu L, Buchy L, Cadenhead KS, Cannon TD, Cornblatt BA, Perkins DO, Seidman LJ, Tsuang MT, Walker EF, Woods SW, Bearden CE, Mathalon DH, McGlashan TH. PMID: 25919383.
      View in: PubMed   Mentions: 42     Fields:    Translation:Humans
    87. Core Schemas in Youth at Clinical High Risk for Psychosis. Behav Cogn Psychother. 2016 Mar; 44(2):203-13. Stowkowy J, Liu L, Cadenhead KS, Cannon TD, Cornblatt BA, McGlashan TH, Perkins DO, Seidman LJ, Tsuang MT, Walker EF, Woods SW, Bearden CE, Mathalon DH, Heinssen R, Addington J. PMID: 25896713.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    88. Reliability of an fMRI paradigm for emotional processing in a multisite longitudinal study. Hum Brain Mapp. 2015 Jul; 36(7):2558-79. Gee DG, McEwen SC, Forsyth JK, Haut KM, Bearden CE, Addington J, Goodyear B, Cadenhead KS, Mirzakhanian H, Cornblatt BA, Olvet D, Mathalon DH, McGlashan TH, Perkins DO, Belger A, Seidman LJ, Thermenos H, Tsuang MT, van Erp TG, Walker EF, Hamann S, Woods SW, Constable T, Cannon TD. PMID: 25821147.
      View in: PubMed   Mentions: 19     Fields:    Translation:Humans
    89. Substance use in individuals at clinical high risk of psychosis. Psychol Med. 2015 Aug; 45(11):2275-84. Buchy L, Cadenhead KS, Cannon TD, Cornblatt BA, McGlashan TH, Perkins DO, Seidman LJ, Tsuang MT, Walker EF, Woods SW, Heinssen R, Bearden CE, Mathalon D, Addington J. PMID: 25727300.
      View in: PubMed   Mentions: 8     Fields:    Translation:HumansAnimals
    90. Factor structure and heritability of endophenotypes in schizophrenia: findings from the Consortium on the Genetics of Schizophrenia (COGS-1). Schizophr Res. 2015 Apr; 163(1-3):73-9. Seidman LJ, Hellemann G, Nuechterlein KH, Greenwood TA, Braff DL, Cadenhead KS, Calkins ME, Freedman R, Gur RE, Gur RC, Lazzeroni LC, Light GA, Olincy A, Radant AD, Siever LJ, Silverman JM, Sprock J, Stone WS, Sugar C, Swerdlow NR, Tsuang DW, Tsuang MT, Turetsky BI, Green MF. PMID: 25682549.
      View in: PubMed   Mentions: 22     Fields:    Translation:Humans
    91. Alcohol confounds relationship between cannabis misuse and psychosis conversion in a high-risk sample. Acta Psychiatr Scand. 2015 Jul; 132(1):60-8. Auther AM, Cadenhead KS, Carrión RE, Addington J, Bearden CE, Cannon TD, McGlashan TH, Perkins DO, Seidman L, Tsuang M, Walker EF, Woods SW, Cornblatt BA. PMID: 25572323.
      View in: PubMed   Mentions: 8     Fields:    Translation:Humans
    92. Stress exposure and sensitivity in the clinical high-risk syndrome: initial findings from the North American Prodrome Longitudinal Study (NAPLS). Schizophr Res. 2014 Dec; 160(1-3):104-9. Trotman HD, Holtzman CW, Walker EF, Addington JM, Bearden CE, Cadenhead KS, Cannon TD, Cornblatt BA, Heinssen RK, Mathalon DH, Tsuang MT, Perkins DO, Seidman LJ, Woods SW, McGlashan TH. PMID: 25443665.
      View in: PubMed   Mentions: 16     Fields:    Translation:Humans
    93. Towards a psychosis risk blood diagnostic for persons experiencing high-risk symptoms: preliminary results from the NAPLS project. Schizophr Bull. 2015 Mar; 41(2):419-28. Perkins DO, Jeffries CD, Addington J, Bearden CE, Cadenhead KS, Cannon TD, Cornblatt BA, Mathalon DH, McGlashan TH, Seidman LJ, Tsuang MT, Walker EF, Woods SW, Heinssen R. PMID: 25103207.
      View in: PubMed   Mentions: 55     Fields:    Translation:Humans
    94. Mismatch Negativity reduction in the left cortical regions in first-episode psychosis and in individuals at ultra high-risk for psychosis. Schizophr Res. 2014 Sep; 158(1-3):58-63. Solís-Vivanco R, Mondragón-Maya A, León-Ortiz P, Rodríguez-Agudelo Y, Cadenhead KS, de la Fuente-Sandoval C. PMID: 25064664.
      View in: PubMed   Mentions: 7     Fields:    Translation:Humans
    95. Current status specifiers for patients at clinical high risk for psychosis. Schizophr Res. 2014 Sep; 158(1-3):69-75. Woods SW, Walsh BC, Addington J, Cadenhead KS, Cannon TD, Cornblatt BA, Heinssen R, Perkins DO, Seidman LJ, Tarbox SI, Tsuang MT, Walker EF, McGlashan TH. PMID: 25012147.
      View in: PubMed   Mentions: 14     Fields:    Translation:Humans
    96. The content of attenuated psychotic symptoms in those at clinical high risk for psychosis. Psychiatry Res. 2014 Nov 30; 219(3):506-12. Marshall C, Denny E, Cadenhead KS, Cannon TD, Cornblatt BA, McGlashan TH, Perkins DO, Seidman LJ, Tsuang MT, Woods SW, Walker E, Addington J. PMID: 25048759.
      View in: PubMed   Mentions: 5     Fields:    Translation:Humans
    97. Progressive reduction in cortical thickness as psychosis develops: a multisite longitudinal neuroimaging study of youth at elevated clinical risk. Biol Psychiatry. 2015 Jan 15; 77(2):147-57. Cannon TD, Chung Y, He G, Sun D, Jacobson A, van Erp TG, McEwen S, Addington J, Bearden CE, Cadenhead K, Cornblatt B, Mathalon DH, McGlashan T, Perkins D, Jeffries C, Seidman LJ, Tsuang M, Walker E, Woods SW, Heinssen R. PMID: 25034946.
      View in: PubMed   Mentions: 121     Fields:    Translation:Humans
    98. Paternal age of schizophrenia probands and endophenotypic differences from unaffected siblings. Psychiatry Res. 2014 Sep 30; 219(1):67-71. Schmeidler J, Lazzeroni LC, Swerdlow NR, Ferreira RP, Braff DL, Calkins ME, Cadenhead KS, Freedman R, Green MF, Greenwood TA, Gur RE, Gur RC, Light GA, Olincy A, Nuechterlein KH, Radant AD, Seidman LJ, Siever LJ, Stone WS, Sprock J, Sugar CA, Tsuang DW, Tsuang MT, Turetsky BI, Silverman JM. PMID: 24913833.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    99. Reliability of functional magnetic resonance imaging activation during working memory in a multi-site study: analysis from the North American Prodrome Longitudinal Study. Neuroimage. 2014 Aug 15; 97:41-52. Forsyth JK, McEwen SC, Gee DG, Bearden CE, Addington J, Goodyear B, Cadenhead KS, Mirzakhanian H, Cornblatt BA, Olvet DM, Mathalon DH, McGlashan TH, Perkins DO, Belger A, Seidman LJ, Thermenos HW, Tsuang MT, van Erp TG, Walker EF, Hamann S, Woods SW, Qiu M, Cannon TD. PMID: 24736173.
      View in: PubMed   Mentions: 24     Fields:    Translation:Humans
    100. Negative symptoms and impaired social functioning predict later psychosis in Latino youth at clinical high risk in the North American prodromal longitudinal studies consortium. Early Interv Psychiatry. 2015 Dec; 9(6):467-75. Alderman T, Addington J, Bearden C, Cannon TD, Cornblatt BA, McGlashan TH, Perkins DO, Seidman LJ, Tsuang MT, Walker EF, Woods SW, Cadenhead KS. PMID: 24576057.
      View in: PubMed   Mentions: 10     Fields:    Translation:Humans
    101. The relationship of neurocognition and negative symptoms to social and role functioning over time in individuals at clinical high risk in the first phase of the North American Prodrome Longitudinal Study. Schizophr Bull. 2014 Nov; 40(6):1452-61. Meyer EC, Carrión RE, Cornblatt BA, Addington J, Cadenhead KS, Cannon TD, McGlashan TH, Perkins DO, Tsuang MT, Walker EF, Woods SW, Heinssen R, Seidman LJ. PMID: 24550526.
      View in: PubMed   Mentions: 38     Fields:    Translation:Humans
    102. Is there an association between advanced paternal age and endophenotype deficit levels in schizophrenia? PLoS One. 2014; 9(2):e88379. Tsuang D, Esterberg M, Braff D, Calkins M, Cadenhead K, Dobie D, Freedman R, Green MF, Greenwood T, Gur R, Gur R, Horan W, Lazzeroni LC, Light GA, Millard SP, Olincy A, Nuechterlein K, Seidman L, Siever L, Silverman J, Stone W, Sprock J, Sugar C, Swerdlow N, Tsuang M, Turetsky B, Radant A. PMID: 24523888.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    103. Biomarkers in psychosis: an approach to early identification and individualized treatment. Biomark Med. 2014; 8(1):51-7. Mirzakhanian H, Singh F, Cadenhead KS. PMID: 24325224.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    104. Substance use in clinical high risk for psychosis: a review of the literature. Early Interv Psychiatry. 2014 May; 8(2):104-12. Addington J, Case N, Saleem MM, Auther AM, Cornblatt BA, Cadenhead KS. PMID: 24224849.
      View in: PubMed   Mentions: 19     Fields:    Translation:Humans
    105. Premorbid functional development and conversion to psychosis in clinical high-risk youths. Dev Psychopathol. 2013 Nov; 25(4 Pt 1):1171-86. Tarbox SI, Addington J, Cadenhead KS, Cannon TD, Cornblatt BA, Perkins DO, Seidman LJ, Tsuang MT, Walker EF, Heinssen R, McGlashan TH, Woods SW. PMID: 24229556.
      View in: PubMed   Mentions: 24     Fields:    Translation:Humans
    106. Functional development in clinical high risk youth: prediction of schizophrenia versus other psychotic disorders. Psychiatry Res. 2014 Jan 30; 215(1):52-60. Tarbox SI, Addington J, Cadenhead KS, Cannon TD, Cornblatt BA, Perkins DO, Seidman LJ, Tsuang MT, Walker EF, Heinssen R, McGlashan TH, Woods SW. PMID: 24200216.
      View in: PubMed   Mentions: 10     Fields:    Translation:Humans
    107. Reliability of neuroanatomical measurements in a multisite longitudinal study of youth at risk for psychosis. Hum Brain Mapp. 2014 May; 35(5):2424-34. Cannon TD, Sun F, McEwen SJ, Papademetris X, He G, van Erp TG, Jacobson A, Bearden CE, Walker E, Hu X, Zhou L, Seidman LJ, Thermenos HW, Cornblatt B, Olvet DM, Perkins D, Belger A, Cadenhead K, Tsuang M, Mirzakhanian H, Addington J, Frayne R, Woods SW, McGlashan TH, Constable RT, Qiu M, Mathalon DH, Thompson P, Toga AW. PMID: 23982962.
      View in: PubMed   Mentions: 24     Fields:    Translation:Humans
    108. Schizophrenia spectrum participants have reduced visual contrast sensitivity to chromatic (red/green) and luminance (light/dark) stimuli: new insights into information processing, visual channel function, and antipsychotic effects. Front Psychol. 2013; 4:535. Cadenhead KS, Dobkins K, McGovern J, Shafer K. PMID: 23970874.
      View in: PubMed   Mentions:
    109. Between-site reliability of startle prepulse inhibition across two early psychosis consortia. Neuroreport. 2013 Aug 07; 24(11):626-30. Cadenhead KS, Addington J, Cannon TD, Cornblatt BA, de la Fuente-Sandoval C, Mathalon DH, Perkins DO, Seidman LJ, Tsuang M, Walker EF, Woods SW, Bachman P, Belger A, Carrión RE, Donkers FC, Duncan E, Johannesen J, León-Ortiz P, Light G, Mondragón A, Niznikiewicz M, Nunag J, Roach BJ, Solís-Vivanco R. PMID: 23799460.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    110. Psychotropic medication use in youth at high risk for psychosis: comparison of baseline data from two research cohorts 1998-2005 and 2008-2011. Schizophr Res. 2013 Aug; 148(1-3):99-104. Woods SW, Addington J, Bearden CE, Cadenhead KS, Cannon TD, Cornblatt BA, Mathalon DH, Perkins DO, Seidman LJ, Tsuang MT, Walker EF, McGlashan TH. PMID: 23787224.
      View in: PubMed   Mentions: 15     Fields:    Translation:Humans
    111. Perceived discrimination in those at clinical high risk for psychosis. Early Interv Psychiatry. 2014 Feb; 8(1):77-81. Saleem MM, Stowkowy J, Cadenhead KS, Cannon TD, Cornblatt BA, McGlashan TH, Perkins DO, Seidman LJ, Tsuang MT, Walker EF, Woods SW, Addington J. PMID: 23773288.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    112. Genome-wide linkage analyses of 12 endophenotypes for schizophrenia from the Consortium on the Genetics of Schizophrenia. Am J Psychiatry. 2013 May; 170(5):521-32. Greenwood TA, Swerdlow NR, Gur RE, Cadenhead KS, Calkins ME, Dobie DJ, Freedman R, Green MF, Gur RC, Lazzeroni LC, Nuechterlein KH, Olincy A, Radant AD, Ray A, Schork NJ, Seidman LJ, Siever LJ, Silverman JM, Stone WS, Sugar CA, Tsuang DW, Tsuang MT, Turetsky BI, Light GA, Braff DL. PMID: 23511790.
      View in: PubMed   Mentions: 57     Fields:    Translation:Humans
    113. Cortisol levels and risk for psychosis: initial findings from the North American prodrome longitudinal study. Biol Psychiatry. 2013 Sep 15; 74(6):410-7. Walker EF, Trotman HD, Pearce BD, Addington J, Cadenhead KS, Cornblatt BA, Heinssen R, Mathalon DH, Perkins DO, Seidman LJ, Tsuang MT, Cannon TD, McGlashan TH, Woods SW. PMID: 23562006.
      View in: PubMed   Mentions: 44     Fields:    Translation:Humans
    114. Reduced P3a amplitudes in antipsychotic naïve first-episode psychosis patients and individuals at clinical high-risk for psychosis. J Psychiatr Res. 2013 Jun; 47(6):755-61. Mondragón-Maya A, Solís-Vivanco R, León-Ortiz P, Rodríguez-Agudelo Y, Yáñez-Téllez G, Bernal-Hernández J, Cadenhead KS, de la Fuente-Sandoval C. PMID: 23507048.
      View in: PubMed   Mentions: 22     Fields:    Translation:Humans
    115. Early traumatic experiences in those at clinical high risk for psychosis. Early Interv Psychiatry. 2013 Aug; 7(3):300-5. Addington J, Stowkowy J, Cadenhead KS, Cornblatt BA, McGlashan TH, Perkins DO, Seidman LJ, Tsuang MT, Walker EF, Woods SW, Cannon TD. PMID: 23343384.
      View in: PubMed   Mentions: 21     Fields:    Translation:Humans
    116. Sexual dimorphisms and prediction of conversion in the NAPLS psychosis prodrome. Schizophr Res. 2013 Mar; 144(1-3):43-50. Walder DJ, Holtzman CW, Addington J, Cadenhead K, Tsuang M, Cornblatt B, Cannon TD, McGlashan TH, Woods SW, Perkins DO, Seidman LJ, Heinssen R, Walker EF. PMID: 23340377.
      View in: PubMed   Mentions: 14     Fields:    Translation:Humans
    117. North American Prodrome Longitudinal Study (NAPLS 2): overview and recruitment. Schizophr Res. 2012 Dec; 142(1-3):77-82. Addington J, Cadenhead KS, Cornblatt BA, Mathalon DH, McGlashan TH, Perkins DO, Seidman LJ, Tsuang MT, Walker EF, Woods SW, Addington JA, Cannon TD. PMID: 23043872.
      View in: PubMed   Mentions: 88     Fields:    Translation:Humans
    118. A developmental look at the attentional system in the at risk and first episode of psychosis: age related changes in attention along the psychosis spectrum. Cogn Neuropsychiatry. 2013; 18(1-2):26-43. Mirzakhanian H, Singh F, Seeber K, Shafer KM, Cadenhead KS. PMID: 22994363.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    119. Visual information processing dysfunction across the developmental course of early psychosis. Psychol Med. 2012 Oct; 42(10):2167-79. Perez VB, Shafer KM, Cadenhead KS. PMID: 22717191.
      View in: PubMed   Mentions: 5     Fields:    Translation:Humans
    120. Negative symptoms in individuals at clinical high risk of psychosis. Psychiatry Res. 2012 Apr 30; 196(2-3):220-4. Piskulic D, Addington J, Cadenhead KS, Cannon TD, Cornblatt BA, Heinssen R, Perkins DO, Seidman LJ, Tsuang MT, Walker EF, Woods SW, McGlashan TH. PMID: 22445704.
      View in: PubMed   Mentions: 69     Fields:    Translation:Humans
    121. Ethical implications for clinical practice and future research in "at risk" individuals. Curr Pharm Des. 2012; 18(4):606-12. Singh F, Mirzakhanian H, Fusar-Poli P, de la Fuente-Sandoval C, Cadenhead KS. PMID: 22239594.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    122. Risk factors for psychosis: impaired social and role functioning. Schizophr Bull. 2012 Nov; 38(6):1247-57. Cornblatt BA, Carrión RE, Addington J, Seidman L, Walker EF, Cannon TD, Cadenhead KS, McGlashan TH, Perkins DO, Tsuang MT, Woods SW, Heinssen R, Lencz T. PMID: 22080497.
      View in: PubMed   Mentions: 60     Fields:    Translation:Humans
    123. Altered age-related trajectories of amygdala-prefrontal circuitry in adolescents at clinical high risk for psychosis: a preliminary study. Schizophr Res. 2012 Jan; 134(1):1-9. Gee DG, Karlsgodt KH, van Erp TG, Bearden CE, Lieberman MD, Belger A, Perkins DO, Olvet DM, Cornblatt BA, Constable T, Woods SW, Addington J, Cadenhead KS, McGlashan TH, Seidman LJ, Tsuang MT, Walker EF, Cannon TD. PMID: 22056201.
      View in: PubMed   Mentions: 27     Fields:    Translation:Humans
    124. Automatic sensory information processing abnormalities across the illness course of schizophrenia. Psychol Med. 2012 Jan; 42(1):85-97. Jahshan C, Cadenhead KS, Rissling AJ, Kirihara K, Braff DL, Light GA. PMID: 21740622.
      View in: PubMed   Mentions: 60     Fields:    Translation:Humans
    125. Strategies for effective recruitment of individuals at risk for developing psychosis. Early Interv Psychiatry. 2011 Aug; 5(3):233-41. Domingues I, Alderman T, Cadenhead KS. PMID: 21707939.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    126. Startle reactivity and prepulse inhibition in prodromal and early psychosis: effects of age, antipsychotics, tobacco and cannabis in a vulnerable population. Psychiatry Res. 2011 Jul 30; 188(2):208-16. Cadenhead KS. PMID: 21555157.
      View in: PubMed   Mentions: 11     Fields:    Translation:Humans
    127. Association of impaired EEG mu wave suppression, negative symptoms and social functioning in biological motion processing in first episode of psychosis. Schizophr Res. 2011 Aug; 130(1-3):182-6. Singh F, Pineda J, Cadenhead KS. PMID: 21549567.
      View in: PubMed   Mentions: 17     Fields:    Translation:Humans
    128. At clinical high risk for psychosis: outcome for nonconverters. Am J Psychiatry. 2011 Aug; 168(8):800-5. Addington J, Cornblatt BA, Cadenhead KS, Cannon TD, McGlashan TH, Perkins DO, Seidman LJ, Tsuang MT, Walker EF, Woods SW, Heinssen R. PMID: 21498462.
      View in: PubMed   Mentions: 130     Fields:    Translation:Humans
    129. Analysis of 94 candidate genes and 12 endophenotypes for schizophrenia from the Consortium on the Genetics of Schizophrenia. Am J Psychiatry. 2011 Sep; 168(9):930-46. Greenwood TA, Lazzeroni LC, Murray SS, Cadenhead KS, Calkins ME, Dobie DJ, Green MF, Gur RE, Gur RC, Hardiman G, Kelsoe JR, Leonard S, Light GA, Nuechterlein KH, Olincy A, Radant AD, Schork NJ, Seidman LJ, Siever LJ, Silverman JM, Stone WS, Swerdlow NR, Tsuang DW, Tsuang MT, Turetsky BI, Freedman R, Braff DL. PMID: 21498463.
      View in: PubMed   Mentions: 118     Fields:    Translation:Humans
    130. Group and site differences on the California Verbal Learning Test in persons with schizophrenia and their first-degree relatives: findings from the Consortium on the Genetics of Schizophrenia (COGS). Schizophr Res. 2011 May; 128(1-3):102-10. Stone WS, Giuliano AJ, Tsuang MT, Braff DL, Cadenhead KS, Calkins ME, Dobie DJ, Faraone SV, Freedman R, Green MF, Greenwood TA, Gur RE, Gur RC, Light GA, Mintz J, Nuechterlein KH, Olincy A, Radant AD, Roe AH, Schork NJ, Siever LJ, Silverman JM, Swerdlow NR, Thomas AR, Tsuang DW, Turetsky BI, Seidman LJ. PMID: 21288694.
      View in: PubMed   Mentions: 17     Fields:    Translation:Humans
    131. Disorganized symptoms and executive functioning predict impaired social functioning in subjects at risk for psychosis. J Neuropsychiatry Clin Neurosci. 2011; 23(4):457-60. Eslami A, Jahshan C, Cadenhead KS. PMID: 22231319.
      View in: PubMed   Mentions: 7     Fields:    Translation:Humans
    132. Treatment history in the psychosis prodrome: characteristics of the North American Prodrome Longitudinal Study Cohort. Early Interv Psychiatry. 2010 Aug; 4(3):220-6. Cadenhead KS, Addington J, Cannon T, Cornblatt B, McGlashan T, Perkins D, Seidman L, Tsuang M, Walker E, Woods S, Heinssen R. PMID: 20712727.
      View in: PubMed   Mentions: 22     Fields:    Translation:Humans
    133. Neuropsychology of the prodrome to psychosis in the NAPLS consortium: relationship to family history and conversion to psychosis. Arch Gen Psychiatry. 2010 Jun; 67(6):578-88. Seidman LJ, Giuliano AJ, Meyer EC, Addington J, Cadenhead KS, Cannon TD, McGlashan TH, Perkins DO, Tsuang MT, Walker EF, Woods SW, Bearden CE, Christensen BK, Hawkins K, Heaton R, Keefe RS, Heinssen R, Cornblatt BA. PMID: 20530007.
      View in: PubMed   Mentions: 132     Fields:    Translation:Humans
    134. Inhibition of the P50 cerebral evoked response to repeated auditory stimuli: results from the Consortium on Genetics of Schizophrenia. Schizophr Res. 2010 Jun; 119(1-3):175-82. Olincy A, Braff DL, Adler LE, Cadenhead KS, Calkins ME, Dobie DJ, Green MF, Greenwood TA, Gur RE, Gur RC, Light GA, Mintz J, Nuechterlein KH, Radant AD, Schork NJ, Seidman LJ, Siever LJ, Silverman JM, Stone WS, Swerdlow NR, Tsuang DW, Tsuang MT, Turetsky BI, Wagner BD, Freedman R. PMID: 20382002.
      View in: PubMed   Mentions: 31     Fields:    Translation:Humans
    135. Antisaccade performance in schizophrenia patients, their first-degree biological relatives, and community comparison subjects: data from the COGS study. Psychophysiology. 2010 Sep; 47(5):846-56. Radant AD, Dobie DJ, Calkins ME, Olincy A, Braff DL, Cadenhead KS, Freedman R, Green MF, Greenwood TA, Gur RE, Gur RC, Light GA, Meichle SP, Millard SP, Mintz J, Nuechterlein KH, Schork NJ, Seidman LJ, Siever LJ, Silverman JM, Stone WS, Swerdlow NR, Tsuang MT, Turetsky BI, Tsuang DW. PMID: 20374545.
      View in: PubMed   Mentions: 21     Fields:    Translation:Humans
    136. Course of neurocognitive deficits in the prodrome and first episode of schizophrenia. Neuropsychology. 2010 Jan; 24(1):109-120. Jahshan C, Heaton RK, Golshan S, Cadenhead KS. PMID: 20063952.
      View in: PubMed   Mentions: 42     Fields:    Translation:Humans
    137. Treatment implications of the schizophrenia prodrome. Curr Top Behav Neurosci. 2010; 4:97-121. Kaur T, Cadenhead KS. PMID: 21312398.
      View in: PubMed   Mentions: 8     Fields:    Translation:Humans
    138. The relation of antipsychotic and antidepressant medication with baseline symptoms and symptom progression: a naturalistic study of the North American Prodrome Longitudinal Sample. Schizophr Res. 2009 Nov; 115(1):50-7. Walker EF, Cornblatt BA, Addington J, Cadenhead KS, Cannon TD, McGlashan TH, Perkins DO, Seidman LJ, Tsuang MT, Woods SW, Heinssen R. PMID: 19709859.
      View in: PubMed   Mentions: 22     Fields:    Translation:Humans
    139. Validity of the prodromal risk syndrome for first psychosis: findings from the North American Prodrome Longitudinal Study. Schizophr Bull. 2009 Sep; 35(5):894-908. Woods SW, Addington J, Cadenhead KS, Cannon TD, Cornblatt BA, Heinssen R, Perkins DO, Seidman LJ, Tsuang MT, Walker EF, McGlashan TH. PMID: 19386578.
      View in: PubMed   Mentions: 117     Fields:    Translation:Humans
    140. Abnormal auditory N100 amplitude: a heritable endophenotype in first-degree relatives of schizophrenia probands. Biol Psychiatry. 2008 Dec 15; 64(12):1051-9. Turetsky BI, Greenwood TA, Olincy A, Radant AD, Braff DL, Cadenhead KS, Dobie DJ, Freedman R, Green MF, Gur RE, Gur RC, Light GA, Mintz J, Nuechterlein KH, Schork NJ, Seidman LJ, Siever LJ, Silverman JM, Stone WS, Swerdlow NR, Tsuang DW, Tsuang MT, Calkins ME. PMID: 18701089.
      View in: PubMed   Mentions: 47     Fields:    Translation:Humans
    141. Verbal working memory impairments in individuals with schizophrenia and their first-degree relatives: findings from the Consortium on the Genetics of Schizophrenia. Schizophr Res. 2008 Aug; 103(1-3):218-28. Horan WP, Braff DL, Nuechterlein KH, Sugar CA, Cadenhead KS, Calkins ME, Dobie DJ, Freedman R, Greenwood TA, Gur RE, Gur RC, Light GA, Mintz J, Olincy A, Radant AD, Schork NJ, Seidman LJ, Siever LJ, Silverman JM, Stone WS, Swerdlow NR, Tsuang DW, Tsuang MT, Turetsky BI, Green MF. PMID: 18406578.
      View in: PubMed   Mentions: 46     Fields:    Translation:Humans
    142. Prediction of psychosis in youth at high clinical risk: a multisite longitudinal study in North America. Arch Gen Psychiatry. 2008 Jan; 65(1):28-37. Cannon TD, Cadenhead K, Cornblatt B, Woods SW, Addington J, Walker E, Seidman LJ, Perkins D, Tsuang M, McGlashan T, Heinssen R. PMID: 18180426.
      View in: PubMed   Mentions: 410     Fields:    Translation:Humans
    143. Initial heritability analyses of endophenotypic measures for schizophrenia: the consortium on the genetics of schizophrenia. Arch Gen Psychiatry. 2007 Nov; 64(11):1242-50. Greenwood TA, Braff DL, Light GA, Cadenhead KS, Calkins ME, Dobie DJ, Freedman R, Green MF, Gur RE, Gur RC, Mintz J, Nuechterlein KH, Olincy A, Radant AD, Seidman LJ, Siever LJ, Silverman JM, Stone WS, Swerdlow NR, Tsuang DW, Tsuang MT, Turetsky BI, Schork NJ. PMID: 17984393.
      View in: PubMed   Mentions: 164     Fields:    Translation:Humans
    144. Obstetrical complications in people at risk for developing schizophrenia. Schizophr Res. 2008 Jan; 98(1-3):307-11. Ballon JS, Dean KA, Cadenhead KS. PMID: 17961986.
      View in: PubMed   Mentions: 6     Fields:    Translation:Humans
    145. Neurocognitive deficits in the (putative) prodrome and first episode of psychosis. Schizophr Res. 2007 Jul; 93(1-3):266-77. Eastvold AD, Heaton RK, Cadenhead KS. PMID: 17467955.
      View in: PubMed   Mentions: 48     Fields:    Translation:HumansPHPublic Health
    146. Social functioning in young people at risk for schizophrenia. Psychiatry Res. 2007 May 30; 151(1-2):29-35. Ballon JS, Kaur T, Marks II, Cadenhead KS. PMID: 17383739.
      View in: PubMed   Mentions: 32     Fields:    Translation:Humans
    147. Cannabis abuse and risk for psychosis in a prodromal sample. Psychiatry Res. 2007 May 30; 151(1-2):151-4. Kristensen K, Cadenhead KS. PMID: 17383738.
      View in: PubMed   Mentions: 33     Fields:    Translation:Humans
    148. Multi-site studies of acoustic startle and prepulse inhibition in humans: initial experience and methodological considerations based on studies by the Consortium on the Genetics of Schizophrenia. Schizophr Res. 2007 May; 92(1-3):237-51. Swerdlow NR, Sprock J, Light GA, Cadenhead K, Calkins ME, Dobie DJ, Freedman R, Green MF, Greenwood TA, Gur RE, Mintz J, Olincy A, Nuechterlein KH, Radant AD, Schork NJ, Seidman LJ, Siever LJ, Silverman JM, Stone WS, Tsuang DW, Tsuang MT, Turetsky BI, Braff DL. PMID: 17346930.
      View in: PubMed   Mentions: 26     Fields:    Translation:Humans
    149. North American Prodrome Longitudinal Study: a collaborative multisite approach to prodromal schizophrenia research. Schizophr Bull. 2007 May; 33(3):665-72. Addington J, Cadenhead KS, Cannon TD, Cornblatt B, McGlashan TH, Perkins DO, Seidman LJ, Tsuang M, Walker EF, Woods SW, Heinssen R. PMID: 17255119.
      View in: PubMed   Mentions: 94     Fields:    Translation:Humans
    150. Startle gating deficits in a large cohort of patients with schizophrenia: relationship to medications, symptoms, neurocognition, and level of function. Arch Gen Psychiatry. 2006 Dec; 63(12):1325-35. Swerdlow NR, Light GA, Cadenhead KS, Sprock J, Hsieh MH, Braff DL. PMID: 17146007.
      View in: PubMed   Mentions: 121     Fields:    Translation:Humans
    151. The Consortium on the Genetics of Endophenotypes in Schizophrenia: model recruitment, assessment, and endophenotyping methods for a multisite collaboration. Schizophr Bull. 2007 Jan; 33(1):33-48. Calkins ME, Dobie DJ, Cadenhead KS, Olincy A, Freedman R, Green MF, Greenwood TA, Gur RE, Gur RC, Light GA, Mintz J, Nuechterlein KH, Radant AD, Schork NJ, Seidman LJ, Siever LJ, Silverman JM, Stone WS, Swerdlow NR, Tsuang DW, Tsuang MT, Turetsky BI, Braff DL. PMID: 17035358.
      View in: PubMed   Mentions: 71     Fields:    Translation:Humans
    152. Successful multi-site measurement of antisaccade performance deficits in schizophrenia. Schizophr Res. 2007 Jan; 89(1-3):320-9. Radant AD, Dobie DJ, Calkins ME, Olincy A, Braff DL, Cadenhead KS, Freedman R, Green MF, Greenwood TA, Gur RE, Light GA, Meichle SP, Mintz J, Nuechterlein KH, Schork NJ, Seidman LJ, Siever LJ, Silverman JM, Stone WS, Swerdlow NR, Tsuang MT, Turetsky BI, Tsuang DW. PMID: 17023145.
      View in: PubMed   Mentions: 35     Fields:    Translation:Humans
    153. Progress in the Prospective Study of the Schizophrenia Prodrome. Curr Psychos Ther Rep. 2005 Dec 01; 3(4):169-174. Fu EJ, Cadenhead KS. PMID: 21691454.
      View in: PubMed   Mentions:
    154. Risk and protection in prodromal schizophrenia: ethical implications for clinical practice and future research. Schizophr Bull. 2006 Jan; 32(1):166-78. Haroun N, Dunn L, Haroun A, Cadenhead KS. PMID: 16207892.
      View in: PubMed   Mentions: 64     Fields:    Translation:Humans
    155. P50 suppression in individuals at risk for schizophrenia: the convergence of clinical, familial, and vulnerability marker risk assessment. Biol Psychiatry. 2005 Jun 15; 57(12):1504-9. Cadenhead KS, Light GA, Shafer KM, Braff DL. PMID: 15953486.
      View in: PubMed   Mentions: 35     Fields:    Translation:Humans
    156. How does studying schizotypal personality disorder inform us about the prodrome of schizophrenia? Curr Psychiatry Rep. 2005 Mar; 7(1):41-50. Seeber K, Cadenhead KS. PMID: 15717986.
      View in: PubMed   Mentions: 20     Fields:    Translation:Humans
    157. The use of the Ego Impairment Index across the schizophrenia spectrum. J Pers Assess. 2003 Feb; 80(1):50-7. Perry W, Minassian A, Cadenhead K, Sprock J, Braff D. PMID: 12584067.
      View in: PubMed   Mentions: 5     Fields:    Translation:Humans
    158. Vulnerability markers in the schizophrenia spectrum: implications for phenomenology, genetics, and the identification of the schizophrenia prodrome. Psychiatr Clin North Am. 2002 Dec; 25(4):837-53. Cadenhead KS. PMID: 12462863.
      View in: PubMed   Mentions: 22     Fields:    
    159. Neurobiological measures of schizotypal personality disorder: defining an inhibitory endophenotype? Am J Psychiatry. 2002 May; 159(5):869-71. Cadenhead KS, Light GA, Geyer MA, McDowell JE, Braff DL. PMID: 11986147.
      View in: PubMed   Mentions: 20     Fields:    Translation:Humans
    160. Dopamine agonist effects on startle and sensorimotor gating in normal male subjects: time course studies. Psychopharmacology (Berl). 2002 May; 161(2):189-201. Swerdlow NR, Eastvold A, Karban B, Ploum Y, Stephany N, Geyer MA, Cadenhead K, Auerbach PP. PMID: 11981599.
      View in: PubMed   Mentions: 23     Fields:    Translation:Humans
    161. Endophenotyping schizotypy: a prelude to genetic studies within the schizophrenia spectrum. Schizophr Res. 2002 Mar 01; 54(1-2):47-57. Cadenhead KS, Braff DL. PMID: 11853978.
      View in: PubMed   Mentions: 9     Fields:    Translation:HumansCells
    162. Lateralized perceptual organization deficits on the global-local task in schizotypal personality disorder. J Abnorm Psychol. 2002 Feb; 111(1):42-52. Granholm E, Cadenhead K, Shafer KM, Filoteo JV. PMID: 11866178.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    163. Saccadic inhibition among schizotypal personality disorder subjects. Psychophysiology. 2001 May; 38(3):399-403. Brenner CA, McDowell JE, Cadenhead KS, Clementz BA. PMID: 11352128.
      View in: PubMed   Mentions: 5     Fields:    Translation:HumansCTClinical Trials
    164. Impact of prepulse characteristics on the detection of sensorimotor gating deficits in schizophrenia. Schizophr Res. 2001 Apr 15; 49(1-2):171-8. Braff DL, Geyer MA, Light GA, Sprock J, Perry W, Cadenhead KS, Swerdlow NR. PMID: 11343875.
      View in: PubMed   Mentions: 91     Fields:    Translation:Humans
    165. Matching strategies for drug studies of prepulse inhibition in humans. Behav Pharmacol. 2001 Feb; 12(1):45-52. Swerdlow NR, Eastvold A, Uyan KM, Ploum Y, Cadenhead K. PMID: 11270511.
      View in: PubMed   Mentions: 6     Fields:    Translation:HumansCTClinical Trials
    166. Modulation of the startle response and startle laterality in relatives of schizophrenic patients and in subjects with schizotypal personality disorder: evidence of inhibitory deficits. Am J Psychiatry. 2000 Oct; 157(10):1660-8. Cadenhead KS, Swerdlow NR, Shafer KM, Diaz M, Braff DL. PMID: 11007721.
      View in: PubMed   Mentions: 84     Fields:    Translation:Humans
    167. Normal P50 suppression in schizophrenia patients treated with atypical antipsychotic medications. Am J Psychiatry. 2000 May; 157(5):767-71. Light GA, Geyer MA, Clementz BA, Cadenhead KS, Braff DL. PMID: 10784470.
      View in: PubMed   Mentions: 55     Fields:    Translation:Humans
    168. Sensory gating deficits assessed by the P50 event-related potential in subjects with schizotypal personality disorder. Am J Psychiatry. 2000 Jan; 157(1):55-9. Cadenhead KS, Light GA, Geyer MA, Braff DL. PMID: 10618013.
      View in: PubMed   Mentions: 52     Fields:    Translation:Humans
    169. Sex differences in sensorimotor gating of the human startle reflex: all smoke? Psychopharmacology (Berl). 1999 Sep; 146(2):228-32. Swerdlow NR, Geyer MA, Hartman PL, Sprock J, Auerbach PP, Cadenhead K, Perry W, Braff DL. PMID: 10525760.
      View in: PubMed   Mentions: 14     Fields:    Translation:HumansCTClinical Trials
    170. Cognitive functions in schizotypal personality disorder. Schizophr Res. 1999 May 25; 37(2):123-32. Cadenhead KS, Perry W, Shafer K, Braff DL. PMID: 10374648.
      View in: PubMed   Mentions: 23     Fields:    Translation:Humans
    171. Prepulse inhibition and habituation of the startle response are stable neurobiological measures in a normal male population. Biol Psychiatry. 1999 Feb 01; 45(3):360-4. Cadenhead KS, Carasso BS, Swerdlow NR, Geyer MA, Braff DL. PMID: 10023514.
      View in: PubMed   Mentions: 26     Fields:    Translation:Humans
    172. Transient versus sustained visual channels in the visual backward masking deficits of schizophrenia patients. Biol Psychiatry. 1998 Jan 15; 43(2):132-8. Cadenhead KS, Serper Y, Braff DL. PMID: 9474445.
      View in: PubMed   Mentions: 41     Fields:    Translation:HumansCTClinical Trials
    173. Information processing deficits of schizophrenia patients: relationship to clinical ratings, gender and medication status. Schizophr Res. 1997 Nov 07; 28(1):51-62. Cadenhead KS, Geyer MA, Butler RW, Perry W, Sprock J, Braff DL. PMID: 9428064.
      View in: PubMed   Mentions: 26     Fields:    Translation:Humans
    174. Backward versus forward visual masking deficits in schizophrenic patients: centrally, not peripherally, mediated? Am J Psychiatry. 1996 Dec; 153(12):1564-70. Saccuzzo DS, Cadenhead KS, Braff DL. PMID: 8942452.
      View in: PubMed   Mentions: 10     Fields:    Translation:Humans
    175. The relationship of information-processing deficits and clinical symptoms in schizotypal personality disorder. Biol Psychiatry. 1996 Nov 01; 40(9):853-8. Cadenhead KS, Perry W, Braff DL. PMID: 8896771.
      View in: PubMed   Mentions: 10     Fields:    Translation:Humans
    176. Clinical and experimental characteristics of "hypothetically psychosis prone" college students. J Psychiatr Res. 1996 Sep-Oct; 30(5):331-40. Cadenhead K, Kumar C, Braff D. PMID: 8923337.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    177. Drug screening in "normal" controls. Biol Psychiatry. 1995 Jul 15; 38(2):123-4. Swerdlow NR, Geyer MA, Perry W, Cadenhead K, Braff DL. PMID: 7578645.
      View in: PubMed   Mentions: 2     Fields:    Translation:HumansPHPublic Health
    178. Abnormality of smooth pursuit eye movement initiation: specificity to the schizophrenia spectrum? Psychophysiology. 1995 Mar; 32(2):130-4. Clementz BA, Reid SA, McDowell JE, Cadenhead KS. PMID: 7630977.
      View in: PubMed   Mentions: 13     Fields:    Translation:Humans
    179. Impaired startle prepulse inhibition and habituation in patients with schizotypal personality disorder. Am J Psychiatry. 1993 Dec; 150(12):1862-7. Cadenhead KS, Geyer MA, Braff DL. PMID: 8238643.
      View in: PubMed   Mentions: 49     Fields:    Translation:Humans
    Kristin's Networks
    Concepts (353)
    Derived automatically from this person's publications.
    _
    Co-Authors (28)
    People in Profiles who have published with this person.
    _
    Similar People (60)
    People who share similar concepts with this person.
    _
    Same Department
    Search Department
    _